AD is a debilitating neurodegenerative disorder characterized by the presence of amyloid-beta (Aβ) senile plaques, NFTs (hyperphosphorylated tau protein), and a decline in neuronal and synaptic function in the brain. This evidence concerns the gene MAPT and Alzheimer disease.